Versiti - Alan E. Mast, MD, PhD | Versiti Blood Research Institute

Alan E. Mast, MD, PhD

Alan E.  Alan E.  profile

Alan E. Mast MD, PhD

Walter Schroeder Endowed Chair for Blood Research, Senior Investigator and Program Leader

Thrombosis and Hemostasis

Walter Schroeder Endowed Chair for Blood Research
Senior Investigator and Program Leader

Versiti Blood Research Institute

Medical Director
Versiti Medical Sciences Institute

Associate Professor
Departments of Pathology and Cell Biology, Neurobiology and Anatomy
Medical College of Wisconsin

Education and training

Doctoral Training
M.D., Ph.D., Duke University, 1991
Residency Training
Anatomic Pathology, Duke University, 1992
Laboratory Medicine, Washington University in St. Louis, 1997

Contact Information
  • 414-937-6310
  • 414-937-6310
  • Thrombosis, Hemostasis and Vascular Biology

    Our laboratory has two distinct research focuses:

    1. Basic science studies of hemostasis and vascular biology with a focus on the physiological function of Tissue Factor Pathway Inhibitor (TFPI)
    2. Clinical and translational research studies of iron metabolism in blood donors

    Basic Science Studies:

    The blood vessel contains several anticoagulant proteins that prevent the formation of blood clots. The work in our laboratory is focused on one of these proteins called tissue factor pathway inhibitor (TFPI). Humans without TFPI have not been identified and genetically altered mice that do not make TFPI die during embryonic development demonstrating that TFPI has critically important physiological functions.  TFPI is a serine protease inhibitor that exerts anticoagulant activity during the very early stages of blood coagulation. Our laboratory uses a wide variety of biochemical, cellular (tissue culture) and animal models to define and characterize the physiological functions of TFPI. These include studies of the biochemical mechanisms that allow TFPI to inhibit blood coagulation proteases and associate with the surface of blood vessels and platelets, characterization and funtional assessment of different alternatively spliced forms of TFPI and the development of new mouse models to examine the function of TFPI in vivo.  The results of these studies will shed new light on a wide range of human bleeding disorders, such as hemophilia, and diseases that are associated or caused by intravascular blood clots, such as deep venous thrombosis, heart attack, stroke and vascular dementia.

    Clinical and Translational Studies:

    Blood donation removes a large amount of iron from the blood donor.  Since blood donation is allowed every 56 days in the United States, repeated donation produces iron deficiency and iron deficiency anemia in many donors.  Thus, blood donors are a unique population of healthy individuals for study of dietary iron absorbtion, hemoglobin production and the adverse consequences of iron deficiency.  We have found that some donors can donate blood repeatedly over many years and not develop iron deficiency anemia suggesting that they are able to absorb dietary iron more efficiently that average.  We perform a variety of studies to define their behavioral, biochemical and genetic characteristics that allow them to donate so frequently and are leading a multi-institutional study to identify the best ways to prevent development of iron deficiency in blood donors.  In addition, we direct the Wisconsin Hub of the National Heart Lung and Blood Institute's Recipient Epidemiology and Donor Evaluation Study (REDS-III).  REDS-III is a multi-institutional group of investigators who perform a number of studies to ensure the safety and availability of blood products in the United States.

    Basic Science Grant Support:
    • National Heart Lung and Blood Institute R01 Award 08/2002-12/2023 (Prinicpal Investigator)
    • Novo Nordisk Research Grant 2007-2020 (Principal Investigator)
    • National Institute for Child Health and Development R01 Award 07/2019-06/2023 (Co-Investigator) 
    Clinical and Translational Studies Grant Support
    • National Heart Lung and Blood Institute Retroviral Epidemiology Donor Study-III (REDS-III) 03/2011-02/2020 (Principal Investigator)
    • National Heart Lung and Blood Institute Retroviral Epidemiology Donor Study-IV-Pediatrics (REDS-IV-P) 03/2019-02/2026 (Principal Investigator)
    • National Heart Lung and Blood Institute R01 Award 01/2011-12/2015 (Principal Investigator)

    Susan Maroney, DVM, PhD
    Research Scientist II

    Julie Peterson, PhD
    Research Scientist II 

    Nicholas Martinez 
    Research Technologist II

    Amy Siebert-McKenzie
    Postdoctoral Fellow

    Selected basic science publications:
    Selected clinical and translational studies publications:
    Thrombosis & Hemostasis
    We study the properties of blood that cause it to clot. Our findings help to treat diseases that cause blood clots or excessive bleeding.
    Join Versiti Blood Research Institute
    Versiti Blood Research Institute, located in Milwaukee, Wisconsin, includes basic and clinical researchers in a variety of blood health fields.
    Our Investigators
    Browse our Investigators, Emeritus Investigators, and other members of the Blood Research Institute.
    Versiti Blood Research Institute
    Versiti Blood Research Institute investigators study blood disorders like hemophilia, blood cancers like leukemia, and other blood diseases.